Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder

@inproceedings{Gonzalez2011ReviewOT,
  title={Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder},
  author={Jodi M. Gonzalez and Peter M. Thompson and Troy A Moore},
  booktitle={Patient preference and adherence},
  year={2011}
}
OBJECTIVE Asenapine is approved for acute manic and mixed states in bipolar disorder. The objective is to review the efficacy of asenapine in bipolar disorder, with a particular focus on acceptability and adherence to treatment. METHODS FIVE CLINICAL TRIALS WERE CONDUCTED IN BIPOLAR DISORDER MANIC OR MIXED STATES: two 3-week trials (n = 976) comparing asenapine to placebo, a 9-week extension (n = 504), and a 40-week extension (n = 107). One trial was conducted comparing asenapine to placebo… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
4 Citations
39 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Asenapine as adjunctive treatment for bipolar mania: results of a placebo-controlled 12-week study and 40-week extension [abstract

  • J Calabrese, L Stet, H Kotari
  • Proceedings of the163rd Annual Meeting of the…
  • 2010
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…